Advertisement
UK markets close in 5 hours 18 minutes

  • FTSE 100

    8,085.22
    +40.41 (+0.50%)
     

  • FTSE 250

    19,803.10
    +3.38 (+0.02%)
     

  • AIM

    754.76
    -0.11 (-0.01%)
     

  • GBP/EUR

    1.1629
    +0.0001 (+0.01%)
     

  • GBP/USD

    1.2430
    -0.0022 (-0.18%)
     

  • Bitcoin GBP

    53,295.89
    +65.39 (+0.12%)
     

  • CMC Crypto 200

    1,432.41
    +8.31 (+0.58%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • CRUDE OIL

    82.96
    -0.40 (-0.48%)
     

  • GOLD FUTURES

    2,328.70
    -13.40 (-0.57%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     

  • DAX

    18,178.72
    +41.07 (+0.23%)
     

  • CAC 40

    8,126.81
    +21.03 (+0.26%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Zealand Pharma to Participate in Upcoming Investor Conferences

Zealand Pharma
·2-min read
Zealand Pharma
Zealand Pharma

Company announcement – No. 50 / 2022

Zealand Pharma to Participate in Upcoming Investor Conferences

Copenhagen, Denmark and Boston, MA, U.S. November 8, 2022 – a Zealand Pharma A/S (CVR-no. 20045078) a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that the company is scheduled to participate in the following investor conferences in November:

Jefferies London Healthcare Conference
Date: Tuesday, November 15, 2022
Presentation: 3:35 a.m. EST / 8:35 a.m. GMT / 9:35 a.m. CET

Evercore ISI Annual HealthCONx Conference (virtual)
Date: Tuesday, November 29, 2022
Presentation: 9:40 a.m. EST / 2:40 p.m. GMT / 3:40 p.m. CET

ADVERTISEMENT

A live webcast of the presentations will be available on the "Events & Presentations" page in the Investor section of the Company's website at https://www.zealandpharma.com/events-presentations. A replay of the webcast will be archived on the Company's website following the presentation.

About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. In addition, license collaborations with Boehringer Ingelheim and AstraZeneca create opportunities for more patients to potentially benefit from Zealand-invented peptide investigational agents currently in development.

Zealand was founded in 1998 and headquartered in Copenhagen, Denmark, with a presence in the U.S. that includes Boston. For more information about Zealand’s business and activities, please visit http://www.zealandpharma.com.

Contacts:
Anna Krassowska, PhD
Vice President, Investor Relations & Corporate Communications
Zealand Pharma
Email: ank@zealandpharma.com

David Rosen (U.S. Media)
Argot Partners
Email: media@zealandpharma.com